ATC Group: V09AX Other central nervous system diagnostic radiopharmaceuticals

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V09AX in the ATC hierarchy

Level Code Title
1 V Various
2 V09 Diagnostic radiopharmaceuticals
3 V09A Central nervous system
4 V09AX Other central nervous system diagnostic radiopharmaceuticals

Group V09AX contents

Code Title
V09AX01 Indium (111In) pentetic acid
V09AX04
V09AX05
V09AX06
V09AX07

Active ingredients in V09AX

Active Ingredient

Florbetaben ¹⁸F binds to β-amyloid neuritic plaques in the brain. It is a radiopharmaceutical indicated for Positron Emission Tomography (PET) imaging of β-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive impairment.

Florbetapir ¹⁸F binds to β-amyloid plaques and the ¹⁸F isotope produces a positron signal that is detected by a PET scanner. Florbetapir ¹⁸F is indicated for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease (AD) and other causes of cognitive decline.

Flutemetamol ¹⁸F binds to β-amyloid neuritic plaques in the brain. It is a radiopharmaceutical medicinal product indicated for Positron Emission Tomography (PET) imaging of β-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD) and other causes of cognitive impairment. VIZAMYL should be used in conjunction with a clinical evaluation.

Related product monographs

Document Type Information Source  
 AMYVID Solution for injection MPI, US: SPL/PLR FDA, National Drug Code (US)
 NEURACEQ Solution for injection MPI, US: SPL/PLR FDA, National Drug Code (US)
 TAUVID Solution for injection MPI, US: SPL/PLR FDA, National Drug Code (US)
 VIZAMYL Solution for injection MPI, US: SPL/PLR FDA, National Drug Code (US)
Go to ATC index
⇈